Prognostic Factors in Adult Acute Lymphoblastic Leukemia

References

• Sandler, D.P. (1992) "Epidemiology and etiology of acute leukemia: an update", Leukemia 6(4), 3–5.
   PubMedGoogle Scholar
• Hoelzer, D., Thiel, E., Löffler, H., Büchner, T., Ganser, A., Heil, G., Koch, P., Freund, M., Dietrich, H., Rühl, H., Maschmeyer, G., Lipp, T., Nowrousian, R.M., Burkert, M., Gerecke, D., Pralle, H., Willer, U., Lunscken, C., Frülle, H., Ho, A.D., Kuchler, R., Busch, F.W., Schneider, W., Görg, C., Emmerich, B., Braumann, D., Vaupel, H.A., von Paleske, A., Bartels, H., Neiss, A. and Messerer, D. (1988) "Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults", Blood 71, 123–131.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H.M., Walters, R.S., Keating, M.J., Smith, T.L., O'Brien, S., Estey, E.H., Huh, Y.O., Spinolo, J., Dicke, K., Barlogie, B., McCredie, K.B. and Freireich, E.J. (1990) "Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard and high-risk acute lymphocytic leukemia", J. Clin. Oncol. 8, 994–1004.
   PubMed Web of Science ®Google Scholar
• Mandelli, F., Annino, L., Vegna, MI., Camera, A., Ciolli, S., Deplano, W., Fabiano, F., Ferrara, F., Ladogana, S., Muti, G., et al. (1992) "GIMEMA ALL 0288, a multicentric study on adult acute lymphoblastic leukemia: preliminary results", Leukemia 6(2), 182–185.
   PubMedGoogle Scholar
• Linker, C.A., Levitt, L.J., O'Donnell, M., Forman, S.J. and Ries, C.A. (1991) "Treatment of adult acute lymphoblastic leukemia with intensive cyclical chemotherapy: a follow-up report", Blood 78, 2814–2822.
   PubMed Web of Science ®Google Scholar
• Radford, J.E., Burns, C.P., Jones, M.P., Gingrich, RD., Kemp, J.D., Edwards, R.W., McFadden, D.B., Dick, F.R. and Chen Wen, B. (1989) "Adult acute lymphoblastic leukemia: results of the Iowa HOP-L protocol", J. Clin. Oncol. 7, 58–66.
   PubMed Web of Science ®Google Scholar
• Larson, R.A., Dodge, R.K., Burns, C.P., Lee, E.J., Stone, R.M., Schulman, P., Duggan, D., Davey, ER., Sobol, R.E., Frankel, SR., Hooberman, AL., Westbrook, C.A., Arthur, D.C., George, S.L., Bloomfield, C.D. and Schiffer, C.A. (1995) "A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia. Cancer and Leukemia Group B study 8811", Blood 85, 2025–2037.
   PubMed Web of Science ®Google Scholar
• Ellison, R.R., Mick, R., Cuttner, J., Schifer, C.A., Silver, R.T., Henderson, E.S., Woliver, T., Royston, I., Davey, ER., Glicksman, AS., et al. (1991) "The effects of postinduction intensification treatment with cytarabine and daunorubicin in adult acute lymphocytic leukemia: a prospective randomised clinical trial by Cancer and Leukemia Group B", J. Clin. Oncol. 9, 2002–2015.
   PubMed Web of Science ®Google Scholar
• Fiere, D., Lepage, E., Sebban, C., Boucheix, C., Gisselbrecht, C., Vernant, J.P., Varet, B., Broustet, A., Calm, J.Y., Rigal-Huguet, F., Witz, E, Michaux, J.L., Michallet, M. and Reiffers, J. for the French Group on Therapy for Adult Acute Lymphoblastic Leukemia (1993) "Adult acute lymphoblastic leukemia: a multicentric randomized trial testing bone marrow trans-plantation as postremission therapy", J. Clin. Oncol. 11, 1990–2001.
   PubMed Web of Science ®Google Scholar
• Hussein, K.K., Dahlberg, S., Head, D., Waddell, C.C., Dabich, L., Weick, J.K., Morrison, F., Said, J.H., Metz, E., Rivkin, SE., Greyer, M.R. and Boldt, D. and the Southwest Oncology Group (1989) "Treatment of acute lymphoblastic leukemia in adults with intensive induction, consolidation, and mainten-ance chemotherapy", Blood 73, 57–63.
   PubMed Web of Science ®Google Scholar
• Thomas, D.A., Cortes, J., O'Brien, S., Pierce, S., Faderl, S., Albitar, M., Hagemeister, F.B., Cabanillas, EE, Murphy, S., Keating, M.J. and Kantarjian, H. (1999) "Hyper-CVAD program in Burkitt's type adult acute lymphocytic leukemia", J. Clin. Oncol. 17, 2461–2470.
   PubMed Web of Science ®Google Scholar
• Gaynor, J., Chapman, D., Little, C., McKenzie, S., Miller, W., Andreeff, M., Arlin, Z., Berman, E., Kempin, S., Gee, T. and Clarkson, B. (1988) "A cause specific hazard rate analysis of prognostic factor among 199 adults with acute lymphoblastic leukemia: The Memorial Hospital experience since 1969", J. Clin. Oncol. 6, 1014–1030.
   PubMed Web of Science ®Google Scholar
• Goker, E., Lin, J.T., Trippett, T., Elisseyeff, Y., Tong, W.P., Niedzwiecld, D., Tan, C., Steinherz, P., Schweitzer, B.I. and Bertino, J.R. (1993) "Decreased polyglutamylation of metho-trexate in acute lymphoblastic leukemia blasts in adults compared to children with this disease", Leukemia 7, 1000–1004.
   PubMed Web of Science ®Google Scholar
• Goasguen, J.E., Dossot, J.M., Fardel, O., LeMee, F., LeGall, E., Leblay, R., LePrise, P.Y., Chaperon, J. and Fauchet, R. (1993) "Expression of the multidrug resistance-associated P-glyco-protein (P-170) in 59 cases of de novo acute lymphoblastic leukemia, prognostic implications", Blood 81, 2394–2398.
   PubMed Web of Science ®Google Scholar
• Nachman, J., Sather, H.N., Buckley, J.D., Gaynon, P.S., Steinherz, E.G., Tubergen, D.C., Lampkin, B.C. and Ham-mond, G.D. (1993) "Young adults 16-21 years of age at diagnosis entered on Children's Cancer Group acute lymphoblastic leukemia and acute myeloblastic leukemia protocols", Cancer 71, 3377–3385.
   PubMed Web of Science ®Google Scholar
• Boissel, N., Auclerc, ME, Lhéritier, V, Perel, Y., Thomas, X., Leblanc, T., Rousselot, E, Cayuela, J.M., Gabert, J., Fegueux, N., Piguet, C., Huguet-Rigal, F., Berthou, C., Boiron, J.M., Pautas, C., Michel, G., Fiere, D., Leverger, G., Dombret, H. and Baruchel, A. (2003) "Should adolescents with acute lymphoblastic leukemia be treated as old children or young adults? Comparison of the French FRALLE-93 and LALA-94 trials", J. Clin. Oncol. 21, 774–780.
   PubMed Web of Science ®Google Scholar
• Chessells, J.M., Hall, E., Prentice, HG., Durrant, J., Bailey, C.C. and Richards, S.M. (1998) "The impact of age on outcome in lymphoblastic leukaemia: MRC UKALL X and XA compared: a report from the MRC Paediatric and Adult Working Parties", Leukemia 12, 463–473.
   PubMed Web of Science ®Google Scholar
• Bassan, R., Battista, R., D'Emilio, A., Viero, P., Dragone, P., Dini, E. and Barbui, T. (1991) "Long-term results of the HEAVD protocol for adult acute lymphoblastic leukaemia", Fur. J. Cancer 27, 441–447.
   Web of Science ®Google Scholar
• Mandelli, E, Annino, L. and Rotoli, B. for the GIMEMA Cooperative Group (1996) "The GIMEMA ALL 0183 trial: analysis of 10-year follow-up", Br. J. Haematol. 92, 665–672.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H.M., O'Brien, S., Smith, T.L., Cortes, J., Giles, F.J., Beran, M., Pierce, S., Huh, Y., Andreeff, M., Koller, C., Ha, CS., Keating, M.J., Murphy, S. and Freireich, E.J. (2000) "Results of treatment with hyper-CVAD, a dose-intensive regimen, in adult acute lymphocytic leukemia", J. Clin. Oncol. 18, 547–561.
   PubMed Web of Science ®Google Scholar
• Cuttner, J., Mick, R., Budman, DR., Mayer, R.J., Lee, E.J., Henderson, ES., Weiss, R.B., Paciucci, P.A., Sobol, R., Davey, F., Bloomfield, C. and Schiffer, C. (1991) "Phase DI trial of brief intensive treatment of adult acute lymphocytic leukemia comparing daunorubicin and mitoxantrone: a CALGB study", Leukemia 5, 425–431.
   PubMed Web of Science ®Google Scholar
• Takeuchi, J., Kyo, T., Naito, K., Sao, H., Takahashi, M., Miyawaki, S., Kuriyama, K., Ohtake, S., Yagasaki, F., Murakami, H., Asou, N., Ino, T., Okamoto, T., Usui, N., Nishimura, M., Shinagawa, K., Fukushima, T., Taguchi, H., Morii, T., Mizuta, S., Aldyama, H., Nakamura, Y., Ohshima, T. and Ohno, R. (2002) "Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and mantenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study", Leukemia 16, 1259–1266.
   PubMed Web of Science ®Google Scholar
• Boggs, D.R., Wintrobe, M.M. and Cartwright, G.E. (1962) "The acute leukemias: analysis of 322 cases and review of the literature", Medicine 41, 163–225.
   PubMed Web of Science ®Google Scholar
• Clarkson, B., Ellis, S., Little, C., Gee, T., Arlin, Z., Mertelsmann, R., Andreeff, M., Kempin, S., Koziner, B., Chaganti, R., et al. (1985) "Acute lymphoblastic leukemia in adults", Semin. Oncol. 12, 160–179.
   PubMed Web of Science ®Google Scholar
• Boucheix, C., David, B., Sebban, C., Racadot, E., Berke, MC., Bernard, A., et al. The French Group on Therapy for Adult Acute Lymphoblastic Leukemia (1994) "Immunophenotype of adult acute lymphoblastic leukemia, clinical parameters and outcome: an analysis of a prospective trial including 562 tested patients (LALA-87)", Blood 84, 1603–1612.
   PubMed Web of Science ®Google Scholar
• Bernard, A., Boumsell, L., Reinherz, E., Nadler, L.M., Ritz, J., Coppin, H., Richard, Y., Valensi, E, Dausset, J., Flandrin, G., Lemerle, J. and Schlossman, S.F. (1981) "Cell surface characterization of malignant T cells from lymphoblastic lymphoma using monoclonal antibodies: evidence for phenotypic differences between malignant T cells from patients with acute lymphoblastic leukemia and lympho-blastic lymphoma", Blood 57, 1105–1110.
   PubMed Web of Science ®Google Scholar
• Ludwig, W.D., Thiel, E., Bartram, C.R., Kranz, BR., Raghavachar, A., Löffler, H., Ganser, A., Biichner, T., Hiddemarm, W., Heil, G., et al. (1990) "Clinical importance of T-ALL subclassification according to thymic or prethymic maturation stage", Haematol. Blood Transfus. 33, 419–427.
   PubMedGoogle Scholar
• Garand, R., Viosin, S., Papin, S., Praloran, V, Lenormand, B., Favre, M., Philip, P., Bernier, M., Vanhaecke, D., Falkenrodt, A., Béné, MC., et al. (1993) "Characteristics of pro-T ALL subgroups: Comparison with late T-ALL. The Groupe d'Etude Immunologique des Leucemies", Leukemia 7, 161–167.
   PubMed Web of Science ®Google Scholar
• Thomas, X., Charrin, C., Magaud, J.P. and Fiere, D. (2001) "CD10 expression in T-lineage adult acute lymphoblastic leukemia", In: Biichner, T., Hiddemarm, W. and Wörmann, B., eds, Acute Leukemias VIII. Prognostic Factors and Treatment Strategies (Springer-Verlag, Berlin), pp 72–77.
   Google Scholar
• Rohatiner, AZ., Bassan, R., Battista, R., Barnett, M.J., Gregory, W., Lim, J., Amess, J., Oza, A., Barbui, T., Horton, M., et al. (1990) "High-dose cytosine arabinoside in the initial treat-ment of adults with acute lymphoblastic leukemia", Br. J. Cancer 62, 454–458.
   PubMed Web of Science ®Google Scholar
• Hoelzer, D., Thiel, E., Löffler, H., Biichner, T., Freund, M., Ganser, A., et al. (1990) "Intensified chemotherapy and mediastinal irradiation in adult T-cell acute lymphoblastic leukemia", In: Gale, R.P. and Hoelzer, D., eds, Acute Lymphoblastic Leukemia (Wiley-Liss, New York, NY), pp 221–229.
   Google Scholar
• Todeschini, G., Meneghini, V, Pizzolo, G., Cassibba, V, Ambrosetti, A., Veneri, D., Nadali, G., Zanotti, R., Tecchio, C. and Perona, G. (1994) "Relationship between daunorubicin dosage delivered during induction therapy and outcome in adult acute lymphoblastic leukemia", Leukemia 8, 376–378.
   PubMed Web of Science ®Google Scholar
• Martin, H., Gökbuget, N., Atta, J., Ludwig, W.D. and Hoelzer, D. for the GMALL Study Group (1998) "Treatment of Ph + and t(4;11) + acute lymphoblastic leukemia", In: Hiddemann, W., Böchner, T. and Wörmann, W., eds, Acute Leukemias VII. Experimental Approaches and Novel Therapies (Springer-Verlag, Berlin), pp 771–778.
   Google Scholar
• Bennett, J.M., Catovsky, D., Daniel, M.T., Flandrin, G., Galton, D.A.G., Gralnick, H.R. and Sultan, C. (1976) "Proposals for the classification of the acute leukaemias. French—American—British (FAB) Co-operative Group", Br. J. Haematol. 33, 451–458.
   PubMed Web of Science ®Google Scholar
• Hoelzer, D. (1994) "Treatment of acute lymphoblastic leukemia", Semin. Haematol. 31, 1–15.
   PubMed Web of Science ®Google Scholar
• Fenaux, P., Lai, J.L., Miaux, O., Zandecki, M., Jouet, J.P. and Bauters, E (1989) "Burkitt cell acute leukaemia (L3 ALL) in adults: a report of 18 cases", Br. J. Haematol. 71, 371–376.
   PubMed Web of Science ®Google Scholar
• Hoelzer, D., Ludwig, W.D., Thiel, E., Gassmarm, W., Löffler, H., Fonatsch, C., Rieder, H., Heil, G., Heinze, B., Arnold, R., Hossfeld, D., Biichner, T., Koch, P., Freund, M., Hiddemarm, W., Maschmeyer, G., Heyll, A., Aul, C., Faak, T., Kuse, R., Ittel, T.H., Gramatzki, M., Diedrich, H., Kolbe, K., Fuhr, HG., Fischer, K., Schadeck-Gressel, C., Weiss, A., Strohscheer, I., Metzner, B., Fabry, U., Gökbuget, N., Völkers, B., Messerer, D. and Uberla, K. (1996) "Improved outcome in adult B-cell acute lymphoblastic leukemia", Blood 87, 495–508.
   PubMed Web of Science ®Google Scholar
• Sobol, RE., Mick, R., Royston, I., Davey, ER., Ellison, R.R., Newman, R., Cuttner, J., Griffin, J.D., Collins, H., Nelson, D.A., et al. (1987) "Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia", N. Engl. J. Med. 316, 1111–1117.
   PubMed Web of Science ®Google Scholar
• Preti, A., Huh, Y, O'Brien, S., Robertson, L., Estey, E. and Beran, M. (1993) "Prognostic significance of positive myeloid markers in adult acute lymphocytic leukemia", Blood 82(1), 57a.
   Google Scholar
• Drexler, HG. and Ludwig, W.D. (1993) "Incidence and clinical relevance of myeloid antigen-positive acute lympho-blastic leukemia", Recent Res. Cancer Res. 131, 53–66.
   PubMedGoogle Scholar
• Guyotat, D., Campos, L., Shi, Z.H., Charrin, C., Treille, D., Magaud, J.P. and Fiere, D. (1990) "Myeloid surface antigen expression in adult acute lymphoblastic leukemia", Leukemia 4, 664–666.
   PubMed Web of Science ®Google Scholar
• Thomas, X., Archimbaud, E., Charrin, C., Magaud, J.P. and Fiere, D. (1995) "CD34 expression associated with major adverse prognostic factors in adult acute lymphoblastic leukemia", Leukemia 9, 249–253.
   PubMed Web of Science ®Google Scholar
• Charrin, C. (1996) "Cytogenetic abnormalities in adult acute lymphoblastic leukemia: correlations with hematologic findings and outcome. A collaborative study of the Groupe Français de Cytogenetique Hematologique", Blood 87, 3135–3142.
   PubMed Web of Science ®Google Scholar
• Secker-Walker, L.M., Prentice, HG., Durrant, J., Richards, S., Hall, E. and Harrison, G. (1997) "Cytogenetics adds independent prognostic information in adults with acute lymphoblastic leukaemia on MRC trial UKALL XA. MRC Adult Leukaemia Working Party", Br. J. Haematol. 96, 601— 610.
   PubMed Web of Science ®Google Scholar
• Mandelli, F., Annino, L., Ciolli, S., Fabbiano, E, Fanin, R., Fioritoni, G., Invernizzi, R., Resegotti, L., Sica, S., Specchia, G., Stasi, R., Tabilio, A. and Visani, G. for the GIMEMA Group (1993) "Philadelphia chromosome (Phi) positive acute lymphoblastic leukemia (ALL) in adults: Interim results of GIMEMA ALL 0288 pilot study", Blood 82(1), 58a.
   Google Scholar
• Secker-Walker, L.M., Craig, J.M., Hawkins, J.M. and Hoff-brand, A.V. (1991) "Philadelphia positive acute lymphoblastic leukemia in adults: Age distribution, BCR breakpoint and prognostic significance", Leukemia 5, 196–199.
   PubMed Web of Science ®Google Scholar
• Bloomfield, C.D., Peterson, L.C., Yunis, J.J. and Brurming, R.D. (1977) "The Philadelphia chromosome in adults presenting with acute leukemia: A comparison of Phi + and Phi- patients", Br. J. Haematol. 36, 347–358.
   PubMed Web of Science ®Google Scholar
• Dombret, H., Gabert, J., Boiron, J.M., Rigal-Huguet, E, Blaise, D., Thomas, X., Delannoy, A., Buzyn, A., Bilhou-Nabera, C., Cayuela, J.M., Fenaux, E, Bourhis, J.H., Fegueux, N., Charrin, C., Boucheix, C., Lheritier, V, Esperou, H., Macintyre, E., Vernant, J.P. and Fiere, D. for the Groupe d'Etude et de Traitement de la Leucemie Aigu6 Lymphoblastique de l'Adulte (GET-LALA Group) (2002) "Outcome of treatment in adults with Philadelphia chromosome-positive acute lymphoblastic leukemia-results of the prospective multi-center LALA-94 trial", Blood 100, 2357–2366.
   PubMed Web of Science ®Google Scholar
• Westbrook, CA., Hooberman, AL., Spino, C., Dodge, R.K., Larson, R.A., Davey, F., Wurster-Hill, D.H., Sobol, RE., Schiffer, C. and Bloomfield, CD. (1992) "Clinical significance of the BCR-ABL fusion gene in adult acute lymphoblastic leukemia: A Cancer and Leukemia Group B study (8762)", Blood 80, 2983–2990.
   PubMed Web of Science ®Google Scholar
• Annino, L., Ferrari, A., Cedrone, M., Giona, E, Lo Coco, F., Meloni, G., Arcese, W. and Mandelli, F. (1994) "Adult Philadelphia-chromosome-positive acute lymphoblastic leu-kemia: Experience of treatments during a ten-year period", Leukemia 8, 664–667.
   PubMed Web of Science ®Google Scholar
• Preti, A., O'Brien, S., Giralt, S., Beran, M., Pierce, S. and Kantarjian, H.M. (1994) "Philadelphia-chromosome-positive adult acute lymphocytic leukemia: characteristics, treatment results, and prognosis in 41 patients", Am. J. Med. 97, 60–65.
   PubMed Web of Science ®Google Scholar
• Thomas, X., Thiebaut, A., Olteanu, N., Danaila, C., Charrin, C., Archimbaud, E. and Fiere, D. (1998) "Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome", Hematol. Cell. Ther. 40, 119–128.
   PubMedGoogle Scholar
• Rieder, H., Ludwig, W.D., Gassmann, W., Maurer, J., Janssen, J.W.G., Gökbuget, N., Schwartz, S., Thiel, E., Löffler, H., Bartram, CR., Hoelzer, D. and Fonatsch, C. (1996) "Prognostic significance of additional chromosome abnorm-alities in adult patients with Philadelphia chromosome positive acute lymphoblastic leukaemia", Br. J. Haematol. 95, 678–691.
   PubMed Web of Science ®Google Scholar
• Götz, G., Weh, H.J., Walter, TA., Kuse, R., Kolbe, K., Dolken, G., Hellriegel, K.P., Hoelzer, D. and Hossfeld, D.K. (1992) "Clinical and prognostic significance of the Philadelphia chromosome in adult patients with acute lymphoblastic leukemia", Ann. Hematol. 64, 97–100.
   PubMed Web of Science ®Google Scholar
• Radich, J., Gehly, G., Lee, A., Avery, R., Bryant, E., Edmands, S., et al. (1997) "Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leu-kemia after marrow transplantation", Blood 89, 2602–2609.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H., Talpaz, M., Dhingra, K., Estey, E., Keating, M.J., Ku, S., et al. (1991) "Significance of the P210 versus P190 molecular abnormalities in adults with Philadelphia chromo-some-positive acute leukemia", Blood 78, 2411–2418.
   PubMed Web of Science ®Google Scholar
• Carrot, A.J., Crist, W.M., Parmley, R.T., Roper, M., Cooper, M.D. and Finley, W.H. (1984) "Pre-B cell leukemia associated with chromosome translocation 1;19", Blood 63, 721–724.
   PubMed Web of Science ®Google Scholar
• Raimondi, S.C., Behm, F.G., Roberson, P.K., Williams, Di., Pui, C.H., Crist, W.M., Look, A.T. and Rivera, G.K. (1990) "Cytogenetics of pre-B-cell acute lymphoblastic leukemia with emphasis on prognostic implications of the t(1;19)", J. Clin. Oncol. 8, 1380–1388.
   PubMed Web of Science ®Google Scholar
• Charrin, C., Dastugue, N., Bilhou-Nabera, B., Mozicconacci, M.J., Jotterand-Bellomo, M., Bastard, C., Hagemeijer, A., Marek, O., Taviaux, S., Lai, J.L., Lheritier, V, Fiere, D. and Thomas, X. for the LALA Group (2002) "Prospective karyotype analysis in adult acute lymphoblastic leukemia: a LALA Group (French—Belgium—Switzerland) report of 730 cases", Blood 100(1), 153a.
   PubMedGoogle Scholar
• Kaneko, Y., Maseki, N., Takasaki, N., Sakurai, M., Hayashi, Y., Nakasawa, S., Mori, T., Sakurai, M., Takeda, T., Shikano, T., et al. (1986) "Clinical and hematologic characteristics in acute leukemia with 11q23 translocations", Blood 67, 484–491.
   PubMed Web of Science ®Google Scholar
• Bloomfield, CD., Secker-Walker, L.M., Goldman, Al., Van den Berghe, H., de la Chapelle, A., Ruutu, T., Alimena, G., Garson, O.M., Golomb, H.M., Rowley, J.D., et al. (1989) "Six-year follow-up of the clinical significance of karyotype in acute lymphoblastic leukemia", Cancer Genet. Cytogenet. 40, 171–185.
   PubMed Web of Science ®Google Scholar
• Ludwig, W.D., Rieder, H., Bartram, CR., Heinze, B., Schwartz, S., Gassmann, W., Löffler, H., Hossfeld, D., Heil, G., Handt, S., Heyll, A., Diedrich, H., Fischer, K., Weiss, A., Völkers, B., Aydemir, U., Fonatsch, C., Gökbuget, N., Thiel, E. and Hoelzer, D. (1998) "Immunophenotypic and genotypic features, clinical characteristics, and treatment outcome of adult pro-B acute lymphoblastic leukemia: Results of the German Multicenter trials GMALL 03/87 and 04/89", Blood 92, 1898–1909.
   PubMed Web of Science ®Google Scholar
• Cortes, J., O'Brien, S., Pierce, S.M., Keating, M.J., Freireich, E.J. and Kantarjian, H.M. (1995) "The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia", Blood 86, 2091–2097.
   PubMed Web of Science ®Google Scholar
• Baccarini, M., Corbelli, G., Amadori, S., Drenthe-Schonk, A., Willemze, R., Meloni, G., Cardozo, P.L., Haanen, C., Mandelli, F. and Tura, S. (1982) "Adolescent and adult acute lymphoblastic leukemia: prognostic features and outcome of therapy: a study of 293 patients", Blood 60, 677–684.
   PubMed Web of Science ®Google Scholar
• List, A.F. (1993) "Multidrug resistance: clinical relevance in acute leukemia", Oncology 7, 23–28.
   PubMedGoogle Scholar
• Leimert, J.T., Burns, C.P., Wiltse, CC., Armitage, J.O. and Clarke, W.R. (1980) "Prognostic influence of pretreatment characteristics in adult acute lymphoblastic leukemia", Blood 56, 510–515.
   PubMed Web of Science ®Google Scholar
• Frisch, B., Bartl, R. and Burkhardt, R. (1982) "Bone marrow biopsy in clinical medicine: an overview", Haematologica 3, 245–285.
   Google Scholar
• Thomas, X., Le, Q.H., Danalla, C., Lheritier, V. and Ffrench, M. (2002) "Bone marrow biopsy in adult acute lympho-blastic leukemia: morphological characteristics and contri-bution to the study of prognostic factors", Leuk. Res. 26, 909–918.
   PubMed Web of Science ®Google Scholar
• Henderson, ES. (1990) "Acute leukemia: general consider-ations", In: Williams, W.J., Beutler, E., Erslev, A.J. and Lichtman, M.A., eds, Hematology (McGraw-Hill, New York), pp 236–251.
   Google Scholar
• Kantarjian, H.M., Walters, R.S., Smith, T.L., Keating, M.J., Barlogie, B., McCredie, K.B. and Freireich, E.J. (1988) "Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia", Blood 72, 1784–1789.
   PubMed Web of Science ®Google Scholar
• Pavlovsky, S., Eppinger-Helft, M. and Sackmann, M.F. (1973) "Factors that influence the appearance of central nervous system leukemia", Blood 42, 935–938.
   PubMed Web of Science ®Google Scholar
• Kantarjian, H.M., Smith, T., Estey, E., Polyzos, A., O'Brien, S., Pierce, S., Beran, M., Feldman, E. and Keating, M.J. (1992) "Prognostic significance of elevated serum beta 2-micro-globulin levels in adult acute lymphocytic leukemia", Am. J. Med. 93, 599–604.
   PubMed Web of Science ®Google Scholar
• Omura, G.A., Moffitt, S., Vogler, W.R. and Salter, M.M. (1980) "Combination chemotherapy of adult acute lymphoblastic leukemia with randomized central nervous system prophy-laxis", Blood 55, 199–204.
   PubMed Web of Science ®Google Scholar
• Schauer, P., Arlin, Z.A., Mertelsmann, R., Cirrincione, C., Friedman, A., Gee, T.S., Dowling, M., Kempin, S., Straus, D.J., Koziner, B., et al. (1983) "Treatment of acute lymphoblastic leukemia in adults: Results of the L-10 and L-10M protocols", J. Clin. Oncol. 1, 462–470.
   PubMed Web of Science ®Google Scholar
• Mahmoud, H.H., Rivera, G.K., Hancock, M.L., Krance, R.A., Kun, L.E., Behm, F.G., Ribeiro, R.C., Sandlund, J.T., Crist, W.M. and Pui, C.H. (1993) "Low leukocyte counts with blast cells in cerebrospinal fluid of children with newly diagnosed acute lymphoblastic leukemia", N. Engl. J. Med. 329, 314–319.
   PubMed Web of Science ®Google Scholar
• Gururangan, S., Sposto, R., Cairo, M.S., Meadows, A.T. and Finlay, J.L. (2000) "Outcome of CNS disease at diagnosis in disseminated small nonclived-cell lymphoma and B-cell leukemia: A Children's Cancer Group study", J. Clin. Oncol. 18, 2017–2025.
   PubMed Web of Science ®Google Scholar
• Kaspers, G.J., Pieters, R., Van Zantwijk, C.H., Van Wering, E.R., Van der Does-Van den Berg, A. and Veerman, A.J. (1998) "Prednisolone resistance in childhood acute lymphoblastic leukemia: Vitro—vivo correlations and cross-resistance to other drugs", Blood 92, 259–266.
   PubMed Web of Science ®Google Scholar
• Sebban, C., Browman, G.P., Lepage, E. and Fiere, D. (1995) "Prognostic value of early response to chemotherapy assessed by the day 15 bone marrow aspiration in adult acute lymphoblastic leukemia: a prospective analysis of 437 cases and its application for designing induction chemother-apy trials", Leuk. Res. 19, 861–868.
   PubMed Web of Science ®Google Scholar
• Linker, C.A. (1997) "Risk-adapted treatment of adult acute lymphoblastic leukemia (ALL)", Leukemia 11, S24—S27.
   PubMedGoogle Scholar
• Le, Q.H., Thomas, X., Ecochard, R., Lheritier, V, Michallet, M. and Fiere, D. (2003) "Individualization of tolerance and disease related prognostic factors using segmented multi-variate analysis for predicting survival in adult acute lymphoblastic leukemia." (submitted).
   Google Scholar
• Thomas, X., Danaila, C., Le, Q.H., Sebban, C., Troncy, J., Charrin, C., Lhéritier, V, Michallet, M., Magaud, J.P. and Fiere, D. (2001) "Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: A single institution experience of 378 consecutive patients over a 21-year period", Leukemia 15, 1811–1822.
   PubMed Web of Science ®Google Scholar